We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$11.3B
AUM Growth
+$388M
(+3.6%)
Cap. Flow
-$337M
Cap. Flow
% of AUM
-2.98%
Top 10 Holdings %
Top 10 Hldgs %
13.82%
Holding
1,006
New
37
Increased
365
Reduced
473
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$30.8M |
| 2 |
UnitedHealth
UNH
|
+$29M |
| 3 |
Simon Property Group
SPG
|
+$25.8M |
| 4 |
Visa
V
|
+$22.9M |
| 5 |
Criteo S.A. Ordinary Shares
CRTO
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$27.1M |
| 2 |
Lowe's Companies
LOW
|
+$21.7M |
| 3 |
VEON
VEON
|
+$20.5M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$20M |
| 5 |
NVIDIA
NVDA
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.2% |
| 2 | Financials | 13.95% |
| 3 | Technology | 13.53% |
| 4 | Consumer Discretionary | 11.82% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Insulet
PODD
$11.8B
| $18.3M | 0.16% |
356,700
+22,640
| +7% | +$983K |
|
152
Clorox
CLX
$11.9B
| $18.3M | 0.16% |
137,217
+28,668
| +26% | +$3.87M |
|
153
Royal Bank of Canada
RY
$292B
| $18.3M | 0.16% |
252,074
+91,015
| +57% | +$6.38M |
|
154
National Health Investors
NHI
$3.68B
| $18.2M | 0.16% |
230,045
+37,023
| +19% | +$2.8M |
|
155
Gen Digital
GEN
$16.9B
| $18.1M | 0.16% |
640,681
-75,353
| -11% | -$2.28M |
|
156
Lam Research
LRCX
$369B
| $18M | 0.16% |
1,273,520
+763,790
| +150% | +$11.2M |
|
|
PGRE
157
DELISTED
Paramount Group
PGRE
| $17.9M | 0.16% |
1,121,109
+316,065
| +39% | +$5.13M |
|
158
Neurocrine Biosciences
NBIX
$16.7B
| $17.9M | 0.16% |
389,626
+180,437
| +86% | +$8.75M |
|
159
Bath & Body Works
BBWI
$4.23B
| $17.8M | 0.16% |
409,635
-3,042
| -0.7% | -$125K |
|
160
Pultegroup
PHM
$24.6B
| $17.8M | 0.16% |
727,000
-255,785
| -26% | -$5.97M |
|
161
Masco
MAS
$14.7B
| $17.8M | 0.16% |
466,481
-14,434
| -3% | -$528K |
|
162
Colgate-Palmolive
CL
$71.9B
| $17.8M | 0.16% |
240,213
-6,756
| -3% | -$502K |
|
|
WP
163
DELISTED
Worldpay, Inc.
WP
| $17.8M | 0.16% |
280,464
-13,951
| -5% | -$876K |
|
164
Cboe Global Markets
CBOE
$31.2B
| $17.4M | 0.15% |
190,884
+15,155
| +9% | +$1.29M |
|
|
XEC
165
DELISTED
CIMAREX ENERGY CO
XEC
| $17.4M | 0.15% |
185,128
+78,626
| +74% | +$8.66M |
|
|
SUM
166
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $17.4M | 0.15% |
620,584
+131,785
| +27% | +$3.43M |
|
167
Illinois Tool Works
ITW
$83B
| $17.3M | 0.15% |
120,754
-59,028
| -33% | -$8.23M |
|
|
MON
168
DELISTED
Monsanto Co
MON
| $17.3M | 0.15% |
145,851
+20,219
| +16% | +$2.36M |
|
|
SHPG
169
DELISTED
Shire pic
SHPG
| $17.3M | 0.15% |
104,456
+3,132
| +3% | +$547K |
|
|
MRO
170
DELISTED
Marathon Oil Corporation
MRO
| $17.1M | 0.15% |
1,442,528
+270,945
| +23% | +$3.79M |
|
171
Waste Management
WM
$90.5B
| $17M | 0.15% |
231,569
-26,278
| -10% | -$1.91M |
|
172
Danaher
DHR
$139B
| $16.9M | 0.15% |
226,421
-80,632
| -26% | -$6.04M |
|
173
Prudential Financial
PRU
$42.7B
| $16.8M | 0.15% |
155,062
+23,887
| +18% | +$2.54M |
|
174
NextEra Energy
NEE
$181B
| $16.6M | 0.15% |
474,832
-3,952
| -0.8% | -$135K |
|
|
NEWR
175
DELISTED
New Relic, Inc.
NEWR
| $16.6M | 0.15% |
386,560
+10,367
| +3% | +$432K |
|
Similar funds
BNP Paribas Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, BNP Paribas Asset Management held 1,006 positions worth $11.3B, up 3.6% from $10.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Asset Management's Q2 2017 filing shows 37 new, 365 increased, 473 reduced and 49 closed positions. Its largest new stake was Gramercy Property Trust: 472,258 shares worth $14M. The largest sale was Alibaba, an estimated $27.1M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- BNP Paribas Asset Management's largest Q2 2017 buy was Gramercy Property Trust: 472,258 shares worth $14M.
- BNP Paribas Asset Management added most to Bristol-Myers Squibb in Q2 2017, an estimated $30.8M increase.
- BNP Paribas Asset Management's biggest Q2 2017 reduction was Alibaba, cutting an estimated $27.1M.
- BNP Paribas Asset Management fully exited CyrusOne Inc Common Stock in Q2 2017, selling an estimated $12.1M.
- BNP Paribas Asset Management's ten largest holdings make up 14% of its $11.3B portfolio in Q2 2017.
- BNP Paribas Asset Management opened 37 new positions and closed 49 in Q2 2017.
- BNP Paribas Asset Management's portfolio value rose 3.6% quarter-over-quarter to $11.3B.
Based on BNP Paribas Asset Management's 13F filing for Q2 2017, filed 4 Aug 2017.